medigraphic.com
ENGLISH

Revista de Gastroenterología de México

Asociación Mexicana de Gastroenterología
  • Mostrar índice
  • Números disponibles
  • Información
    • Información general        
    • Directorio
  • Publicar
    • Instrucciones para autores        
  • medigraphic.com
    • Inicio
    • Índice de revistas            
    • Registro / Acceso
  • Mi perfil

2005, Número 4

<< Anterior Siguiente >>

Rev Gastroenterol Mex 2005; 70 (4)


Utilidad de las escalas diagnósticas para cáncer de colon no polipósico hereditario en la población mexicana

Mendoza SA, Sobrino CS, Hernández GA, Córdova PVH, Alonso LO, Sánchez DJ
Texto completo Cómo citar este artículo Artículos similares

Idioma: Español
Referencias bibliográficas: 49
Paginas: 411-415
Archivo PDF: 46.64 Kb.


PALABRAS CLAVE

cáncer de colon no polipósico hereditario (CCNPH), criterios de Ámsterdam, criterios de Ámsterdam II, criterios de Bethesda.

RESUMEN

Introducción: el cáncer de colon no polipósico hereditario (CCNPH) representa de 2 a 7% de todas de las neoplasias malignas del colon, el diagnóstico se realiza por los criterios de Ámsterdam, Ámsterdam modificados y Bethesda. Objetivo: evaluar la utilidad clínica de las escalas diagnósticas para CCNPH en nuestra población y determinar las características clínicas que nos puedan predecir a un caso de CCNPH. Material y métodos: estudio retrospectivo, transversal, se incluyó a pacientes con cáncer de colon menores de 50 años en un periodo de tres años. Se recabaron los datos demográficos, antecedentes familiares, edad del diagnóstico y características del tumor. Se aplicaron los criterios de Ámsterdam, Ámsterdam modificados y Bethesda. Resultados: cincuenta y seis de 210 pacientes con cáncer de colon fueron menores de 50 años con una edad media de 38.3 años, 14.3% tenía antecedentes familiares oncológicos. En 53.6% el tumor se localizó en el colon derecho e histológicamente predominó el componente mucinoso y pobre diferenciación celular. Sólo dos pacientes cumplieron con los criterios de Ámsterdam y Ámsterdam modificados y ninguno cumplió con los criterios de Bethesda. Conclusión: la frecuencia de CCNPH en nuestra población es de 1% por los criterios de Ámsterdam y Ámsterdam modificados y 0% por los criterios de Bethesda.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Berends MJW, Wu Y, Sijmons RH, et al. Clinical definition of hereditary non-polyposis colorectal cancer: a search for the impossible? Scand J Gastroenterol 2001; 36(Suppl. 234): 61-7.

  2. Lawes DA, SenGupta SB, Boulos PB. Patogénesis and clinical management of herediary non-poliposis colorectal cancer. Br J Surg 2002; 89: 1357-69.

  3. Lynch HT, De la Chapelle A. Hereditary colorectal cancer. NEJM 2003; 348: 919-32.

  4. Gafa R, Maestri I, Matteuzzi M, et al. Sporadic colorectal adenocarcinoma with high-frequency microsatellite instability. Cancer 2000; 89: 2025-37.

  5. Lindor NM, Burgart LJ, Leontoich O, et al. Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. J Clin Oncol 2002; 20: 1043-8.

  6. Thibodeau SN, French AJ, Cunningham JM, et al. Microsatellite instability in colorectal cancer: different matador phenotypes and the principal involvement of hMLH1. Cancer Research 1998; 58: 1713-18.

  7. Dietmaier W, Wallinger S, Bocker T, et al. Diagnostic microsatellite inestablity: definition and correlation with mismatch repair protein expression. Cancer Research 1997; 57: 4749-56.

  8. Grann VR, Jacobson JS. Population screening for cancer-related germline gene mutations. Lancet Oncology 2002; 3: 102-9.

  9. Minardi Jr AJ, Sittig KM, Zibari GB, et al. Colorectal cancer in the young patient. Am Surg 1998; 64: 849-53.

  10. Aaltonen LA, Peltomaki P, Leach GS, Sistonen P, Pylkanene, L, Meclin, JP, et al. Clues to the pathogenesis of familial colorectal cancer. Science 1993; 260: 812-6.

  11. Miyaki M, Konishi M, Tanaka K, et al. Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer. Nat Genet 1997; 17: 221-2.

  12. Simstein NL, Kovalcik PJ, Cross GH. Colorectal carcinoma in patients less than 40 years old. Dis Colon Rectum 1978; 21: 169-71.

  13. Martin Jr EW, Joyce S, Lucas J, et al. Colorectal carcinoma in patients less than 40 years of agepathology and prognosis. Dis Colon Rectum 1981; 24: 25-8.

  14. Gallagher EG, Zeigler MG. Rectal carcinoma in patients in the second and third decades of life. Am J Surg 1972; 124: 655-9.

  15. Griffin PM, Liff JM, Greenberg RS, et al. Adenocarcinomas of the colon and rectum in persons under 40 years old. A population-based study. Gastroenterology 1991; 100: 1033-40.

  16. Cusack JC, Giacco GG, Cleary K, et al. Survival factors in 186 patients younger than 40 years old with colorectal adenocarcinoma. J Am Coll Surg 1996; 183: 105-12.

  17. Raymond PL, Skelton DS, Hsu HS. Young patients with colorectal cancer the University of Mississippi Medical Center experience 1970-1990. J Miss State Med Assoc 1991; 32: 298-304.

  18. Adkins Jr RB, DeLozier JB, McKnight WG, et al. Carcinoma of the colon in patients 35 years of age and younger. Am Surg 1987; 53: 141-5.

  19. Moore PA, Dilawari RA, Fidler WJ. Adenocarcinoma of the colon and rectum in patients less than 40 years of age. Am Surg 1984; 50: 10-4.

  20. Coffey R, Cardenas F. Cancer of the bowel in the young adult. Dis Colon Rectum 1964; 7: 491-2.

  21. Miller F, Liechty R. Adenocarcinoma of the colon and rectum in persons under thirty years of age. Am J Surg 1967; 113: 507-10.

  22. Rosato FE, Frazier TG, Copeland EM, et al. Carcinoma of the colon in young people. Surg Gynecol Obstet 1969; 129: 29-32.

  23. Sanfelippo PM, Beahrs OH. Carcinoma of the colon in patients under forty years of age. Surg Gynecol Obstet 1974; 138: 169-70.

  24. Howard EW, Cavallo C, Hovey LM, et al. Colon and rectal cancer in the young adult. Am Surg 1975; 41: 260-5.

  25. Walton WW, Hagihara PF, Griffen WO. Colorectal adenocarcinoma in patients less than 40 years old. Dis Colon Rectum 1976; 19: 529-34.

  26. Scarpa JF, Hartmann WH, Sawyers JL. Adenocarcinoma of the colon and rectum in young adults. South Med J 1976; 69: 24-7.

  27. Bulow S. Colorectal cancer in patients less than 40 years of age in Denmark, 1943–1967. Dis Colon Rectum 1980; 23: 327-36.

  28. Bedikian AY, Kantarjian H, Nelson RS, et al. Colorectal cancer in young adults. South Med J 1981; 74: 920-4.

  29. Ohman U. Colorectal carcinoma in patients less than 40 years of age. Dis Colon Rectum 1982; 25: 209-14.

  30. Pitluk H, Poticha SM. Carcinoma of the colon and rectum in patients less than 40 years of age. Surg Gynecol Obstet 1983; 157: 335-7.

  31. Mosley Jr EL, Chung EB, Cornwell EE, et al. Colorectal carcinoma in young persons experience at Howard University Hospital, 1955–1977. J Natl Med Assoc 1979; 71: 449-51.

  32. Ahlberg J, Bergstrand O, Holmstrom B, et al. Malignant tumours of the colon and rectum in patients aged 30 and younger. Acta Chir Scand 1980; 500: 29-31.

  33. Beckman EN, Gathright JB, Ray JE. A potentially brighter prognosis for colon carcinoma in the third and fourth decades. Cancer 1984; 54: 1478-81.

  34. Jarvinen HJ, Turunen MJ. Colorectal carcinoma before 40 years of age prognosis and predisposing conditions. Scand J Gastroenterol 1984; 19: 634-8.

  35. Turkiewicz D, Miller B, Schache D, et al. Young patients with colorectal cancer how do they fare? ANZ J Surg 2001; 71: 707-10.

  36. Parramore JB, Wei JP, Yeh KA. Colorectal cancer in patients under forty presentation and outcome. Am Surg 1998; 64: 563-8.

  37. Yilmazlar T, Zorluoglu A, Ozguc H, et al. Colorectal cancer in young adults. Tumori 1995; 81: 230-3.

  38. Marble K, Banerjee S, Greenwald L. Colorectal carcinoma in young patients. J Surg Oncol 1992; 51: 179-82.

  39. Shahrudin MD, Noori SM. Cancer of the colon and rectum in the first three decades of life. Hepatogastroenterology 1997; 44: 441-4.

  40. Cozart DT, Lang NP, Hauer-Jensen M. Colorectal cancer in patients under 30 years of age. Contributors to the South-western Surgical Congress Unusual Case Registry. Am J Surg 1993; 166: 764-7.

  41. Lundy J, Welch JP, Berman M. Colorectal cancer in patients under 40 years of age. J Surg Oncol 1983; 24: 11-4.

  42. Okuno M, Ikehara T, Nagayama M, et al. Colorectal carcinoma in young adults. Am J Surg 1987; 154: 264-8.

  43. Hulten L, Kewenter J, Ahren C, et al. Clinical and morphological characteristics of colitis carcinoma and colorectal carcinoma in young people. Scand J Gastroenterol 1979; 14: 673-8.

  44. McCoy GF, Parks TG. Colorectal carcinoma in young patients. A 20-year retrospective review. J R Coll Surg Edinb 1984; 29: 129-33.

  45. Umpleby HC, Williamson RC. Large bowel cancer in the young. Ann Acad Med Singapore 1987; 16: 456-61.

  46. Domergue J, Ismail M, Astre C, et al. Colorectal carcinoma in patients younger than 40 years of age. Montpellier Cancer Institute experience with 78 patients. Cancer 1988; 61: 835-40.

  47. D’Onofrio GM, Tan EG. Is colorectal carcinoma in the young a more deadly disease? Aust N Z J Surg 1985; 55: 537-40.

  48. Fantelli F, Sebek B. Adenocarcinoma of the colon and rectum in the young adult. (Abstr) Lab Invest 1980; 42: 19.

  49. Gryfe R, Kim H, Hsieh ETK, et al. Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. NEJM 2004; 342: 69-77.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Gastroenterol Mex. 2005;70

ARTíCULOS SIMILARES

CARGANDO ...